Placental mesenchymal dysplasia is associated with high rates of intrauterine growth restriction and fetal demise: A report of 11 new cases and a review of the literature.

Placental mesenchymal dysplasia (PMD) is a rare condition of placentomegaly and abnormal chorionic villi often clinically mistakenly as partial hydatidiform mole. However, it is clinicopathologically distinct with high incidence of intrauterine growth restriction (IUGR) and fetal death. This study presents 11 new PMD cases and provides a meta-analysis of the associated IUGR and fetal death rates. The cases were identified between 1971 and 2005, mostly from consultation files. To our knowledge, 71 PMD cases have previously been reported; 15 of these were associated with Beckwith-Wiedemann syndrome (BWS). With the addition of our new results, among all cases without BWS, 50% had IUGR and 43% had intrauterine fetal demise (IUFD) or neonatal death. Females represented 82% of cases. Thus, PMD is associated with high IUGR and IUFD/neonatal death rates and disproportionally affects females. The cause and pathogenesis are yet unknown. The current understanding and hypotheses involving PMD are discussed.

[1]  M. Alberry,et al.  Management of fetal growth restriction , 2006, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[2]  C. Livasy,et al.  Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia , 2005, Journal of Medical Genetics.

[3]  N. Sebire,et al.  Placental mesenchymal dysplasia associated with fetal aneuploidy , 2005, Prenatal diagnosis.

[4]  R. Redline Severe fetal placental vascular lesions in term infants with neurologic impairment. , 2005, American journal of obstetrics and gynecology.

[5]  R. Redline Clinical and pathological umbilical cord abnormalities in fetal thrombotic vasculopathy. , 2004, Human pathology.

[6]  D. Brodsky,et al.  Current Concepts in Intrauterine Growth Restriction , 2004, Journal of intensive care medicine.

[7]  D. Monk,et al.  Intrauterine growth restriction--genetic causes and consequences. , 2004, Seminars in fetal & neonatal medicine.

[8]  D. Roberts,et al.  Fetal Vascular Obstructive Lesions: Nosology and Reproducibility of Placental Reaction Patterns , 2004, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[9]  E. S. Suarez,et al.  Mesenchymal dysplasia of the placenta. , 2004, Placenta.

[10]  A. Sampson,et al.  Placental mesenchymal dysplasia: A report of four cases with differentiation from partial hydatidiform mole , 2003, The Australian & New Zealand journal of obstetrics & gynaecology.

[11]  A. Mitsuhashi,et al.  Placental mesenchymal dysplasia initially diagnosed as partial mole , 2003, Pathology international.

[12]  M. Nakayama,et al.  Suspected involvement of the X chromosome in placental mesenchymal dysplasia , 2002, Congenital anomalies.

[13]  N. Sebire,et al.  Pseudo‐partial moles: placental stem vessel hydrops and the association with Beckwith–Wiedemann syndrome and complete moles , 2001, Histopathology.

[14]  J. Magee Investigation of Stillbirth , 2001, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[15]  Yukichi Tanaka,et al.  Mesenchymal dysplasia of the placenta , 2000, Pathology international.

[16]  M. Furuhashi,et al.  Hydrops of placental stem villi complicated with fetal congenital adrenal hyperplasia , 2000, Archives of Gynecology and Obstetrics.

[17]  E. Ruchelli,et al.  Hepatic Mesenchymal Hamartoma Associated with Mesenchymal Stem Villous Hyperplasia of the Placenta , 2000, Fetal Diagnosis and Therapy.

[18]  K. Benirschke,et al.  Pathology of the Human Placenta , 1992, Springer New York.

[19]  K. Benirschke,et al.  Benign Tumors: Chorangiosis , 2000 .

[20]  F. Kraus,et al.  Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. , 1999, Human pathology.

[21]  K. Benirschke Recent Trends in Chorangiomas, Especially Those of Multiple and Recurrent Chorangiomas , 1999, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[22]  W. Wells,et al.  Focal aneurysmal dilatation of subchorionic vessels simulating chorioangioma , 1999, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[23]  K. Nicolaides,et al.  Perinatal features associated with placental mesenchymal dysplasia. , 1997, Placenta.

[24]  Chih-ping Chen,et al.  Pregnancy with concomitant chorangioma and placental vascular malformation with mesenchymal hyperplasia. , 1997, Human reproduction.

[25]  Y. Hirata,et al.  Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. , 1997, Genomics.

[26]  J. Hustin,et al.  Partial Mole and Triploidy: Screening Patients With First‐Trimester Spontaneous Abortion , 1996, Obstetrics and gynecology.

[27]  J. Gillan,et al.  Trophoblast basement membrane haemosiderosis in the placental lesion of fetal artery thrombosis: a marker for disturbance of maternofetal transfer? , 1995, Placenta.

[28]  K. Benirschke,et al.  Normative Values and Tables , 1995 .

[29]  L. Wilkins-Haug,et al.  Sonographic appearance of placental villous hydrops associated with Beckwith‐Wiedemann syndrome. , 1995, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[30]  L. Sunde,et al.  Placental vascular malformation with mesenchymal hyperplasia and a localized chorioangioma. A rarity simulating partial mole. , 1994, Pathology, research and practice.

[31]  L. McCowan,et al.  Beckwith‐wiedemann syndrome, placental abnormalities, and gestational proteinuric hypertension , 1994, Obstetrics and gynecology.

[32]  Wells Wa,et al.  Ultrasound placental cysts associated with massive placental stem villous hydrops, diploid DNA content, and exomphalos , 1994 .

[33]  R. Weksberg,et al.  Disruption of insulin–like growth factor 2 imprinting in Beckwith–Wiedemann syndrome , 1993, Nature genetics.

[34]  Sander Cm Angiomatous malformation of placental chorionic stem vessels and pseudo-partial molar placentas: report of five cases. , 1993 .

[35]  J. Resau,et al.  The effect of immersion formaldehyde fixation on human placental weight. , 1991, Archives of Pathology & Laboratory Medicine.

[36]  J. Lage Placentomegaly with massive hydrops of placental stem villi, diploid DNA content, and fetal omphaloceles: possible association with Beckwith-Wiedemann syndrome. , 1991, Human pathology.

[37]  J. Hustin,et al.  Placental vascular anomaly with diffuse mesenchymal stem villous hyperplasia. A new clinico-pathological entity? , 1991, Pathology, research and practice.

[38]  J. Chi,et al.  An unusual venous anomaly of the placenta. , 1991, American journal of clinical pathology.

[39]  A. Feinberg,et al.  Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. , 1989, American journal of human genetics.

[40]  J. Hobbins,et al.  SONOGRAPHIC DIAGNOSIS OF A PREGNANCY WITH A DIFFUSE HYDATIDIFORM MOLE AND COEXISTENT 46,XX FETUS: A CASE REPORT , 1988, Obstetrics and gynecology.

[41]  K. Ohama,et al.  Cytogenetic and Clinicopathologic Studies of Partial Moles , 1986, Obstetrics and gynecology.

[42]  M. Takayama,et al.  Abnormally large placenta associated with Beckwith-Wiedemann syndrome. , 1986, Gynecologic and Obstetric Investigation.

[43]  G. Altshuler Chorangiosis. An important placental sign of neonatal morbidity and mortality. , 1984, Archives of pathology & laboratory medicine.

[44]  C. Sander Hemorrhagic endovasculitis and hemorrhagic villitis of the placenta. , 1980, Archives of pathology & laboratory medicine.

[45]  D. Edelman,et al.  A standard of fetal growth for the United States of America. , 1976, American journal of obstetrics and gynecology.